14 jan: SUPER SUPPER I EN KOLD TID
18 jan: Udsigt til stærkt 1. halvår på aktiemarkederne
14-01-2011 17:02:34

Ad hoc reports in accordance with Sec. 15 of the German Securities Trading Act - Dräger increases net sales in 2010 by around 14 percent

Drägerwerk AG & Co. KGaA /

Ad hoc reports in accordance with Sec. 15 of the German Securities Trading Act -

Dräger increases net sales in 2010 by around 14 percent

Processed and transmitted by Thomson Reuters.

The issuer is solely responsible for the content of this announcement.

EBIT margin at the upper limit of the forecast 

According to preliminary estimates, Drägerwerk AG & Co. KGaA achieved net sales growth of around 14 percent and record net sales of EUR 2.2 billion in 2010 compared to EUR 1.9 billion in 2009. In October 2010, the company still anticipated net sales growth around 10 percent. The EBIT margin reached 8 to 9 percent, the upper limit of the 2010 forecast. Order intake rose by around 9 percent year on year to EUR 2.2 billion. 

The medical division recorded order intake of around 8 percent and generated net sales of EUR 1.5 billion - an increase of approximately 17 percent compared to the previous year. The EBIT margin was around 12 percent according to preliminary estimates. In the safety division, order intake went up by about 10 percent and net sales reached EUR 0.7 billion, corresponding to a rise of around 9 percent compared to 2009. The EBIT margin came to around 9 percent according to preliminary estimates. 

The reasons for the positive net sales and earnings development were the unexpectedly high order intake in the fourth quarter of 2010, continuous positive developments in the Americas and Asia/Pacific and favorable currency effects. The turnaround program also had an extremely positive effect. 

In 2011, Dräger will invest even larger sums into research and development, implement projects even more quickly and improve its marketing and sales organization in particular. For this reason, Dräger expects slightly higher group net sales in 2011 and an EBIT margin between 7.5 percent and 8.5 percent. The estimated development of net sales and margins in fiscal year 2011 is based on the assumption that the markets relevant to Dräger will continue their steady development and that exchange rates will remain at the current level. In the medium term, the company plans to grow faster than the market and achieve a minimum EBIT margin of 10 percent in the long term.

 

Drägerwerk AG & Co. KGaA

Moislinger Allee 53-55

23558 Lübeck, Deutschland

www.draeger.com  

Investor Relations:

Vanina Hoffmann

Phone:+49 451 882-2685

vanina.hoffmann@draeger.com 

Corporate Communications:

Burkard Dillig

Phone +49 451 882-2185

burkard.dillig@draeger.com 

 

Disclaimer

This press release contains forward-looking statements regarding the future development of the Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to it to date and have been prepared to the best of its knowledge and belief. No guarantee or liability for the occurrence of the future developments and results specified can be assumed in respect of such forward-looking statements. Rather, the future developments and results are dependent on a number of factors. They entail risks and uncertainties beyond the Company's control and are based on assumptions which could prove to be incorrect. Notwithstanding any legal requirements to adjust forecasts, we assume no obligation to update the forward-looking statements contained in this report. You will find all other financial dates on our website at www.draeger.com under Investor Center/Financial Calendar.

Press release (PDF)

--- End of Message ---

Drägerwerk AG & Co. KGaA

Moislinger Allee 53-55 Lübeck Germany

Listed: Freiverkehr in Börse Stuttgart,

Prime Standard in Frankfurter Wertpapierbörse,

Regulierter Markt in Frankfurter Wertpapierbörse,

Regulierter Markt in Bayerische Börse München,

Regulierter Markt in Börse Berlin,

Regulierter Markt in Hanseatische Wertpapierbörse zu Hamburg,

Regulierter Markt in Börse Düsseldorf,

Regulierter Markt in Niedersächsische Börse zu Hannover;

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the

information contained therein.

Source: Drägerwerk AG & Co. KGaA via Thomson Reuters ONE

HUG#1479951

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
26 okt
VWS
Fra tid til anden lytter jeg til Solveig Bjørnestad’s P1 Business. Hun er dygtig til at lave en 360 ..
36
27 okt
VWS
Normal 0 21 false false false DA X-NONE X-NONE ..
26
28 okt
I:SP500
Det ser grundlæggende ganske fint ud makroøkonomisk, hvilket ikke er det samme som at der ikke finde..
16
26 okt
BAVA
Jeg synes du skulle lade være med at bekymre dig om kortsigtede udsving, og ganske enkelt gå lang i ..
16
28 okt
VWS
 Fredag d. 3. okt. i år var den norske Olie- og energiminister Tord Lien og næstformand for det nors..
14
29 okt
VWS
Hej Pokerchamp, det du kalder 'amatør-detektiv'-arbejde er langt mere informativt end dine ukonstruk..
12
30 okt
VWS
Jeg sad ellers lige og kiggede endnu en ordre i Polen   34 MW Postolin Wind Farm   Den ordre må være..
11
30 okt
DANSKE
Og pludselig savner jeg alligevel den der "røde tommel ned"  der endgang var her på EI 
11
29 okt
FING-B
Swift - det er jo fuldkommen ligegyldigt hvad vi siger eller gør så synes du og dit slæng det er for..
11
26 okt
 
Læg mærke til medierne altid fokuserer på de dårlige nyheder! Verden er af lava og vi hører konstant..
11

Schouw/CEO: Har flere opkøb i kikkerten

30-10-2014 15:39:25
Industrikonglomeratet Schouw & Co. har appetit på yderligere opkøb til sine porteføljevirksomheder.Det siger selskabets administrerende direktør Jens Bjerg Søre..

Novo/S&P Capital: Hæver kursmål til 273 kr. fra 253 kr.

30-10-2014 13:03:29
Analytikerne hos S&P Capital IQ er blevet mere positivt stemt over for Novo Nordisk-aktien.I hvert fald hæver finanshuset kursmålet til 273 kr. fra tidligere 25..

Aktier/åbning: Danske Bank og Novo fører an efter regnskaber

30-10-2014 09:14:46
To af de tunge spillere i eliteindekset C20, Danske Bank og Novo Nordisk, kom torsdag morgen med kvartalsregnskaber inden børsåbning.Og det er da også de to akt..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Novo Q3: 2014-forventninger skuffer i forhold til konsensus
2
Novo/Sydbank: Levemir-tal gør frygt til skamme
3
Coloplast Q4: Absolut ingen slinger i valsen
4
Aktier/tendens: Novo fører an i regnskabsbølge
5
Danske Q3: Opjusterer efter overraskende stærkt kvartal
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
31. oktober 2014 07:07:33
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20141028.2 - EUROWEB7 - 2014-10-31 07:07:33 - 2014-10-31 07:07:33 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x